Skip to main content

Table 2 Characteristics and medical use of CABG patients in medical center A during 2005-2008

From: Is it possible to identify cases of coronary artery bypass graft postoperative surgical site infection accurately from claims data?

 

All

Non-SSI

SSI

P-value

N

1017

993 (97.64)

24 (2.36)

 

Male

795 (78.2%)

781 (78.65)

14 (58.33)

0.017

Age (years)

65.03 (10.86)

64.98 (10.86)

67.14 (10.95)

0.949

Number of vessels obstructed

1.88 (0.34)

1.89 (0.33)

1.67 (0.56)

<0.001

Length of stay (days)

18.09 (12.64)

17.11 (6.60)

58.29 (58.72)

<0.001

Length of stay (days)*

16 (8)

16 (7)

47.5 (21.5)

 

Type of antibiotics

1.57 (1.00)

1.51 (0.90)

3.71 (2.10)

<0.001

Doses of antibiotics

8.27 (9.05)

7.89 (8.43)

24.07 (16.84)

<0.001

Use of cefazolin

998 (97.15)

975 (98.19)

13 (54.17)

<0.001

Doses of cefazolin

3.93 (2.18)

3.96 (2.12)

2.65 (3.61)

<0.001

ICD-9-CM SSI code

45 (4.4%)

36 (3.63)

9 (37.50)

<0.001

Use of second-line antibiotics

115 (11.58)

115 (11.58)

20 (83.33)

<0.001

  1. CABG: coronary artery bypass graft; SSI: surgical site infection.
  2. Mean(S.D) N(%) *Median(IQR).